Key statistics
On Tuesday, Reneo Pharmaceuticals Inc (OKUR:NMQ) closed at 19.21, 96.00% above the 52 week low of 9.80 set on Dec 14, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 18.50 |
---|---|
High | 19.60 |
Low | 17.49 |
Bid | 19.14 |
Offer | 19.39 |
Previous close | 18.65 |
Average volume | 42.21k |
---|---|
Shares outstanding | 3.34m |
Free float | 316.94k |
P/E (TTM) | -- |
Market cap | 62.34m USD |
EPS (TTM) | -16.82 USD |
Data delayed at least 15 minutes, as of Oct 08 2024.
More ▼
Announcements
- OnKure Announces Closing of Merger with Reneo Pharmaceuticals and Concurrent Private Placement of $65 Million
- Reneo Pharmaceuticals Announces Stockholder Approval of Merger with OnKure
- Reneo Pharmaceuticals Reports Second Quarter 2024 Financial Results
- Reneo Pharmaceuticals and OnKure Announce Proposed Merger
- Reneo Pharmaceuticals Reports First Quarter 2024 Financial Results
- Reneo Pharmaceuticals Reports Fourth Quarter And Full Year 2023 Financial Results And Business Update
- Reneo Pharmaceuticals Announces Results from Pivotal STRIDE Study of Mavodelpar in Primary Mitochondrial Myopathies (PMM)
- Reneo Pharmaceuticals Reports Third Quarter 2023 Financial Results
- Reneo Pharmaceuticals to Participate in Upcoming Investor Conferences
- Reneo Pharmaceuticals Announces Poster Presentation at Upcoming Scientific Meetings
More ▼